Immune cells after prolonged Natalizumab therapy: implications for effectiveness and safety. Marousi S, Karkanis I, Kalamatas T, Travasarou M, Paterakis G, Karageorgiou CE Acta Neurol Scand. 2013 Jan 11. PMID: 23311457. Abstract CommentRecommendBookmarkWatch